Drug Index



Indication :

• Juvenile Idiopathic Arthritis

• Crohn’s disease

• Uveitis

Dosing :

JIA and Uveitis:

>2 years:

10 to 14 kg: 10 mg SC once in 2 weeks.

15 to 29 kg: 20 mg SC once in 2 weeks.

30 kg and above: 40 mg SC once in 2 weeks.

Crohn’s disease:

Use only in children above 6 years.

17-39 kg: 80 mg SC followed by 40 mg after 2 weeks and then 20 mg every 2 weeks.

>40 kg: 160 mg SC followed by 80 mg after 2 weeks and then 40 mg every 2 weeks.

Adverse Effect :

Injection site pain, Headache, URI, nausea, infections, back pain, hypertension, rash, body pain, hypersensitivity, hyperlipidemia, abdominal pain, hematuria, increased alkaline phosphatase, fever, hepatitis, sarcoidosis, neoplasms, GBS, pulmonary fibrosis, alopecia, Steven Johnson syndrome, systemic vasculitis.

Hepatic Dose :

No dosage adjustments are recommended.
07/29/2020 09:25:06 Adalimumab
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0